Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

WSE/MAB stock hub

WSE/MAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WSE/MABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

122.5M

Warsaw Stock Exchange

Market data

Price

Recent price action with selectable time range.

WSE/MABWSE/MAB

—

Loading chart…

In the news

Latest news · WSE/MAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-78.1

P25 n/aP50 n/aP75 n/a

ROIC-83.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WSE/MAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

PLN

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Poland
Country code	PL
Employees	213
Employees Change	-34%
Employees Change Percent	-13.77
Enterprise value	PLN 128.8M
Exchange	Warsaw Stock Exchange
Financial currency	PLN
First seen	2026-05-10
Industry	Biotechnology
Isin	PLMBION00016
Last refreshed	2026-05-10
Market cap	PLN 122.5M
Price	PLN 7.58
Price currency	PLN
Rev Per Employee	75,033.33x
Sector	Healthcare
Sic	2836
Symbol	wse/MAB
Website	https://www.mabion.eu

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-51.11%
EV Earnings	-2.06x
EV/FCF	-3.03x
EV/Sales	8.18x
FCF yield	-34.68%
P/B ratio	2.51x
P/S ratio	7.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA Margin	-269.77%
Gross margin	-110.52%
Gross Profit	PLN -17.4M
Net Income	PLN -62.6M
Net Income Growth Years	0%
Pretax Margin	-397.37%
Profit Per Employee	PLN -298,162
ROA	-23.9
Roa5y	-2.51
ROCE	-77.51
ROE	-78.14
ROIC	-83.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-18.8%
Cagr15y	-2.51%
Cagr1y	-26.85%
Cagr3y	-25.07%
Cagr5y	-31.04%
EPS Growth Years	0
Revenue Growth	-77.17x
Revenue Growth Q	19.92x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-54.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PLN 0.12
Assets	PLN 110.4M
Cash	PLN 6.4M
Current Assets	PLN 12.8M
Current Liabilities	PLN 43.9M
Debt	PLN 12.7M
Debt Equity	PLN 0.26
Debt FCF	PLN -0.3
Equity	PLN 48.8M
Interest Coverage	-13.89
Liabilities	PLN 61.6M
Long Term Assets	PLN 97.6M
Long Term Liabilities	PLN 17.8M
Net Cash	PLN -6.3M
Net Cash By Market Cap	PLN -5.16
Net Debt Equity	PLN 0.13
Tangible Book Value	PLN 48.7M
Tangible Book Value Per Share	PLN 3
WACC	8.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.29
Net Working Capital	PLN -36M
Quick ratio	0.27
Working Capital	PLN -31.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-87.53%
1Y total return	-26.83%
200-day SMA	8.41
3Y total return	-57.94%
50-day SMA	8.37
50-day SMA vs 200-day SMA	50under200
5Y total return	-84.4%
All Time High	139
All Time High Change	-94.55%
All Time High Date	2018-01-15
All Time Low	6.7
All Time Low Change	13.13%
All Time Low Date	2025-12-19
ATR	0.35
Beta	0.41
Beta1y	0.13
Beta2y	0.57
Ch YTD	8.6
High	7.81
High52	10.6
High52 Date	2025-05-19
High52ch	-28.49%
Low	7.47
Low52	6.7
Low52 Date	2025-12-19
Low52ch	13.13%
Ma50ch	-9.38%
Price vs 200-day SMA	-9.84%
RSI	40.09
RSI Monthly	35.26
RSI Weekly	40.74
Sharpe ratio	-0.9x
Sortino ratio	-1.33
Total Return	0.38%
Tr YTD	8.6
Tr15y	-31.71%
Tr1m	-11.45%
Tr1w	2.43%
Tr3m	-7.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN -51.6M
Operating margin	-327.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,295,878%
Net Borrowing	10,141,000
Shares Institutions	0.07%
Shares Out	16,162,326
Shares Qo Q	1.13%
Shares Yo Y	-0.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PLN -42.5M
Average Volume	37,768.2x
Bv Per Share	3.01
CAPEX	PLN -892,000
Ch10y	-87.53
Ch15y	-31.71
Ch1m	-11.45
Ch1w	2.43
Ch1y	-26.83
Ch3m	-7.67
Ch3y	-57.94
Ch5y	-84.4
Ch6m	-5.49
Change	5.28%
Change From Open	-2.82
Close	7.2
Days Gap	8.33
Depreciation Amortization	9,095,000
Dollar Volume	551,012.9
Earnings Date	2026-04-28
EBIT	PLN -51.6M
EBITDA	PLN -42.5M
EPS	PLN -3.87
F Score	1
FCF	PLN -42.5M
FCF EV Yield	-32.98x
FCF Per Share	PLN -2.63
Financing CF	10,309,000
Fiscal Year End	December
Founded	2,007
Investing CF	-795,000
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2025-12-31
Ma150	8.12
Ma150ch	-6.67%
Ma20	8.01
Ma20ch	-5.31%
Net CF	-32,076,000
Next Earnings Date	2026-05-19
Open	7.8
Position In Range	32.35
Ppne	95,485,000
Price Date	2026-05-08
Ptbv Ratio	2.52
Relative Volume	2.06x
Revenue	15,757,000x
Tr6m	-5.49%
Volume	72,693

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WSE/MAB pay a dividend?

Capital-return profile for this ticker.

Performance

WSE/MAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WSE/MAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.4%

Negative means the company is buying back shares.

Technical

WSE/MAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.1

Neutral momentum band

Price vs 200-day MA

-9.8%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

-0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WSE/MAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/MAB stock rating?

wse/MAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/MAB analysis?

The full report lives at /stocks/wse/MAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/MAB?

The latest report frames wse/MAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/MAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.